Steven Blinka

3PUBLICATIONS
13CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 13, 2026
SPEN inactivation drives resistance to androgen receptor pathway inhibitors in metastatic prostate cancer.

|Sep 09, 2025
Drug Targets in Prostate Cancer: An Appetite for KLK2-Mediated Destruction.

Steven Blinka, Evan Y Yu

|Dec 15, 2023
Citron Kinase Is a Druggable Target in Treatment-Resistant Prostate Cancer.

Rashmi Mishra, Steven Blinka, Andrew C Hsieh

Pageof 1